Sygnis Bioscience GmbH & Co KG
1 clinical trials · Sponsor
◉ Watch Sygnis Bioscience GmbH & Co KG
| Record | Firm | Date |
|---|---|---|
| AXIS 2: AX200 for the Treatment of Ischemic Stroke (NCT00927836) | Sygnis Bioscience GmbH & Co KG | 2009-05-01 |
Track Sygnis Bioscience GmbH & Co KG automatically
Every clearance here is in the API, with alerts when new ones post.